Alembic Pharmaceuticals Q2 FY27 Post-Results Conference Call

Event Type: Post Results Conference Call exclusively for analysts and institutional investors
Date and Time: Wednesday, 4th November, 2026 at 4:00 P.M. IST
Purpose: To discuss the Company's Q2 FY27 Unaudited Financial Results with the Senior Management Team
Management Participants: The document mentions "Senior Management Team Members" but does not specify individual names or designations
Presentation Availability: No specific mention of presentation decks, transcripts, or recordings being made available
UPSI Compliance: Standard regulatory disclosure format suggests no unpublished price sensitive information will be shared

Period Discussed: Q2 FY27 (Second Quarter of Financial Year 2026-2027) unaudited financial results
Financial Data Disclosed: No financial figures, guidance references, or strategic updates are included in this announcement

Registration Option: Diamond Pass registration available at provided secure link for direct access without operator assistance
Dial-in Numbers: Multiple options provided:
Universal Access Numbers: +91 22 6280 1411, +91 22 7115 8312
India Toll Free: 1 800 120 1221
International Toll Free:
USA: 1866 746 2133
UK: 080 810 11573
Singapore: 800 101 2045
Hong Kong: 800 96 4448

Contact Information: Isha Lamba (Phone: +91 22-66951652, Email: isha.lamba@alembic.co.in) for further information
Attachments: The letter mentions "Encl.: A/a" indicating some attachment was included, though not specified in detail
Financial Data: No financial data or performance metrics were disclosed in this announcement
Compliance: Standard regulatory filing format with digital signature by Company Secretary Chirag K. Shukla